BDTX

Conviction 19HealthcareScan · Mon, Aug 10, 2026

BDTX$1.98+1.54%

ResistanceSupportVol 14

Vol MA14 665.06K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Black Diamond Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.blackdiamondtherapeutics.com ↗

Price1.98

Change+1.54%

Gap+0.00%

Rel volume1.26×

Avg volume675.53K

Avg $ vol1.22M

SMA 201.80

SMA 501.85

SMA 2002.58

Price vs 50+7.15%

Price vs 200-23.17%

MA stackmixed

50/200 cross—

Supertrenddown · 1.99

RSI (14)60

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D91 / 92

ADX (14)14

+DI / −DI27 / 15

RSI divergence—

MACD divergence—

ATR %+5.53%

ADR %5.00%

52w high4.87

52w low1.61

From 52w high-59.34%

Above 52w low+22.98%

New 52w highNo

SqueezeFired

Bollinger width18.01%

%B1.04

Donchian pos91.14%

Donchian high2.02

Donchian low1.62

AVWAP (52w high)2.52

vs AVWAP high-21.42%

AVWAP (52w low)1.82

vs AVWAP low+8.59%

OBV trendFlat

Chaikin MF (20)0.05

Today vs 20d1.26×

Avg vol (14d)665.06K

Avg vol (20d)675.53K

Avg $ vol (20d)1.22M

Market cap113.76M

RS 3m (vs SPY)-34.01%

RS 6m (vs SPY)-23.84%

RS line new highNo

Trend template1/8

Technical rank40.9

1 week+14.12%

1 month+3.66%

3 months-33.78%

6 months-12.20%

1 year-13.16%

YTD-20.48%

P/E5.09

P/B1.18

P/S—

P/FCF3.84

EPS0.3900

Div yield—

ROE23.28%

ROA17.89%

Debt/Eq—

Current7.28

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth132.10%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value94.56M

Revenue—

Net income-9.9M

Gross profit—

Free cash flow29.61M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out57.3M

Employees21

ListedThu, Jan 30, 2020

Free float41.48M

Float %72.8%

Short interest5.85M

Days to cover3.7d

Short volume48.7%

Squeeze score57 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction19 / 100

Pattern quality—

Tech rank40.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.10

Support1.61

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BDTX

All disclosures →

No recent disclosed trades by Congress in BDTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BDTX · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Behbahani Ali Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Dhingra Kapil Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Menzel Garry E Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Kulkarni Samarth Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Raman Prakash Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Campbell Shannon Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Behbahani Ali Director · Common Stock · 2026-06-19	Grant	8.96K	$15K	2026-06-19	2026-06-22
Raman Prakash Director · Common Stock · 2026-06-19	Grant	7.91K	$13K	2026-06-19	2026-06-22

SEC filings

EDGAR filings in BDTX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.